HYBRID EVENT: You can participate in person at Paris, France or Virtually from your home or work.

6th Edition of World Congress on Infectious Diseases

June 24-26, 2024 | Paris, France

June 24 -26, 2024 | Paris, France
Infection 2023

Jernell Robert D Malixi

Speaker at Infectious Diseases Conference - Jernell Robert D Malixi
Laguna Medical Center, Philippines
Title : Three year retrospective study on the survival analysis of ventilator acquired pneumonia adult patients at Batangas Medical Center, Philippines

Abstract:

Background:
Hospital Acquired Pneumonia is an important public health concern. Even with the advent of new anti-bacterials, there is an increasing prevalence of anti-microbial resistance worldwide. In particular, Ventilator Acquired Pneumonia can increase mortality risk in patients admitted. Batangas Medical Center is a multi-specialty tertiary hospital located at Batangas City which caters different diseases. Due to increased number of patients, hospital acquired pneumonia can be acquired which can complicate existing diseases especially for intubated patients. However, there is no existing data on Ventilator Acquired Pneumonia Patient’s survival analysis done in this institution.

Objectives:
This study aims to determine the clinico-demographic profile and survival analysis of adult patients diagnosed with Ventilator Acquired Pneumonia at a tertiary government hospital.

Methodology:
The study was a retrospective cohort study at Batangas Medical Center from January 2017 to December 31, 2019.

Results:
The study included two hundred thirty-one patients diagnosed with ventilator acquired pneumonia. It concluded that majority of isolated bacteria were Acinetobacter baumannii (33%), Klebsiella pneumoniae (22%), and Pseudomonas aeruginosa (12.68%). Among Pandrug resistant organisms, Acinetobacter baumannii was frequently isolated followed by Klebsiella pneumoniae. There were no significant findings on the survival analysis of VAP patients based on age, sex, and co-morbidities. In this study, it showed that patients who underwent tracheostomy had significant decreased mortality as compared to patients without surgical intervention

Conclusion:
Ventilator acquired pneumonia was a risk factor on morbidity and mortality among adult patients admitted at a tertiary hospital. Among the different risk factors (age, sex, comorbidities and surgical intervention), tracheostomy decreased mortality and morbidity of patients diagnosed with ventilator acquired pneumonia.

Audience Take Away:

  • Explain the prevalence of ventilator acquired pneumonia at a tertiary government hospital in the Philippines.
  • Determine clinico-demographic factors affecting the survival of ventilator acquired pneumonia patients.
  • For clinicians, it can help on determine on empiric treatment needed for patients based on clinico- demographic profile.
  • This research can help other clinician and researchers study on Ventilator Acquired Pneumonia especially on other intervention such as early or delayed tracheostomy.

Biography:

Dr. Jernell Robert D. Malixi finished his medicine degree at University of the City of Manila, Philippines in 2014. He joined the Doctors-to-the-Barrio program under the Department of Health wherein he provides clinical services in Geographically Isolated and Disadvantaged Areas. While providing health services in far flung areas, He finished his Masters in Public Management Major in Health Systems and Development at the Development Academy of the Philippines, Manila. In 2021, he finished his residency training on Internal Medicine at Batangas Medical Center, Philippines.

Watsapp